GoodRx Holdings (GDRX) Gross Profit (2019 - 2026)

GoodRx Holdings' Gross Profit history runs 8 years deep, the most recent figure standing at $113.0 million for Q1 2026.

• In Q1 2026, Gross Profit fell 4.62% year-over-year to $113.0 million; the TTM figure through Mar 2026 stood at $733.8 million (up 165.25% YoY), while the FY2025 annual figure was $739.3 million, up 73.86% from the prior year.
• Gross Profit came in at $113.0 million for Q1 2026 at GoodRx Holdings, down from $390.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $390.1 million in Q4 2025 to a low of -$132.5 million in Q4 2024.
• A 5-year average of $102.0 million and a median of $112.5 million in 2025 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit tumbled 44.8% in 2023 and surged 394.42% in 2025, its largest moves.
• GoodRx Holdings' Gross Profit stood at -$125.8 million in 2022, then increased by 26.13% to -$92.9 million in 2023, then slumped by 42.59% to -$132.5 million in 2024, then soared by 394.42% to $390.1 million in 2025, then slumped by 71.05% to $113.0 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $113.0 million, $390.1 million, and $112.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison